In a small randomized trial, electroacupuncture treatment produced improvements in gait speed, handgrip strength, and muscle mass in hemodialysis patients with sarcopenia, while control group metrics declined over the same 8-week period . The mechanism may involve changes in lipid and amino acid metabolism, though the study size limits confidence in the findings.
Sarcopenia, the progressive loss of skeletal muscle mass and strength, represents a serious complication for patients on maintenance hemodialysis. These individuals already face metabolic stress from kidney disease and the dialysis procedure itself, making muscle preservation particularly challenging. This new study from the Journal of Cachexia, Sarcopenia and Muscle tested whether electroacupuncture, an acupuncture variant using electrical stimulation, could address this problem in this vulnerable population.
The trial enrolled 35 hemodialysis patients (mean age 59 years) with confirmed sarcopenia, randomly assigning them to receive either 24 sessions of electroacupuncture (three times weekly for 8 weeks) or to continue their standard treatment without intervention. Electroacupuncture needles were stimulated electrically for 30 minutes per session. The researchers measured three primary outcomes: walking speed over 6 meters, handgrip strength, and skeletal muscle mass index (SMI) calculated from body composition assessment.
The differences between groups were directionally consistent. In the electroacupuncture group, 6-meter gait speed increased by 0.10 meters per second (p < 0.001), while the control group's speed declined by 0.06 m/s (p = 0.018). Handgrip strength increased by 0.68 kg in the treatment group (p = 0.011) versus a decline of 0.76 kg in controls (p = 0.015). Skeletal muscle mass index rose by 0.19 units in the electroacupuncture group (p = 0.003), with no significant change in controls. No serious adverse events occurred during treatment. The researchers also conducted serum metabolomics analysis, identifying 127 differentially expressed metabolites between groups. Pathway analysis suggested changes in lipid metabolism and amino acid profiles, proposing a mechanistic link between electroacupuncture and the observed muscle improvements.
The effect sizes appeared moderate in magnitude. While the improvements are clinically meaningful for a population where decline is the typical trajectory, the absolute changes are small in real-world terms, particularly the gait speed improvement of 0.10 m/s. This reflects both the severity of sarcopenia in hemodialysis patients and the constraints of a short intervention period. The study's design, with control group decline offsetting active group improvement, strengthens the case for a true effect, but the sample size of 35 participants and lack of longer-term follow-up remain limitations.
If you're managing sarcopenia as a hemodialysis patient: This study provides preliminary evidence that electroacupuncture merits consideration as an adjunct to standard care, particularly since the intervention carried no serious adverse effects in this trial. However, this single study is not sufficient to establish it as standard practice. Discuss electroacupuncture options with your nephrologist and dialysis care team, ideally seeking practitioners experienced with hemodialysis patients.
If you're interested in sarcopenia management more broadly: The metabolomic findings hint at electroacupuncture's possible systemic effects on metabolism, but the current evidence is most specific to this hemodialysis population. Other evidence-supported approaches for sarcopenia include resistance training and adequate protein intake, combined with targeted supplementation like creatine monohydrate in appropriate contexts. These should remain first-line considerations.
Regarding timing and accessibility: Eight weeks of three-weekly electroacupuncture sessions represents a meaningful time commitment. The trial doesn't clarify whether benefits persist after treatment ends or if maintenance sessions are needed, questions that future research should address.
| Parameter | Details |
|---|---|
| Study type | Randomized controlled trial |
| Sample size | 35 participants (24 treatment, 11 control) |
| Population | Maintenance hemodialysis patients with sarcopenia; mean age 59.1 years |
| Intervention | 24 electroacupuncture sessions, 30 minutes each, 3x weekly for 8 weeks |
| Control | Standard treatment continuation |
| Primary outcome | 6-meter gait speed |
| Secondary outcomes | Handgrip strength; skeletal muscle mass index |
| Mechanistic measure | Serum metabolomics (LC-MS) |
| Duration | 8 weeks |
| Adverse events | None reported as serious |
| Journal | Journal of Cachexia, Sarcopenia and Muscle |
| Evidence tier | : Small RCT with positive findings but limited sample size and short follow-up |
Study: Electroacupuncture Treatment on Sarcopenia in Patients Undergoing Maintenance Haemodialysis: An Effective Therapy. PubMed
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.